Compare Amphastar Pharmaceuticals Inc (AMPH) vs Box Inc (BOX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Box Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $18.72 (market cap $826.08M), while Box Inc trades at $28.64 (market cap $3.97B). The key difference: Box Inc is far larger — about 4.8× Amphastar Pharmaceuticals Inc's market cap, and Box Inc is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | BOX | |
|---|---|---|
Market Cap | $826.08M | $3.97B |
Sector | Health | Technology |
52-Week High | $30.81 | $33.55 |
52-Week Low | $16.87 | $21.37 |
Enterprise Value | $1.22B | $4.52B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
BOX trades at $28.64, down 0.56% today, with strong analyst support (17 Buy, 10 Hold, 1 Sell) and a $37.00 consensus price target representing 29% upside. The company shows robust revenue growth from $874M in 2022 to $1.09B in 2025, with net income surging to $244.62M. Recent expansion of Box Zones in Switzerland, Israel, and Singapore (Business Wire, June 30, 2026) enhances global data governance capabilities. Technical indicators show bullish moving averages but overbought RSI levels.
BOX presents a compelling growth story with expanding profitability and strategic international expansion, though elevated valuation multiples (P/E 44.75) require continued execution. Key risks include competitive cloud storage pressures and debt levels, while institutional sentiment remains positive with significant upside to price targets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Box Inc
Box is a cloud-based content services platform that provides cloud-based storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file sync and sharing provider. More recently, however, the company has focused on bolstering its product portfolio by adding tools such as governance and e-signature that enhance workflow management and collaboration.
Read more on BOX →
